ClinicalTrials.gov
public full text
Public Domain
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.
A 12-Month Observational Prospective Multicentre Cohort Study based on existing and newly collected data of schizophrenia patients followed-up for one year in secondary care settings (psychiatric services). Schizophrenia patients will be enrolled in a consecutive manner over a period of 6 month into two cohorts according to their prescribing switching treatment: to lurasidone (cohort A) and to another SGA (cohort B).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia#994198
- Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse#1126433
- A Long-Term, Open-Label, Study on Schizophrenia#978999
- A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres#878037
- Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia#912991
Record · ID 1196567
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive